Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar
暂无分享,去创建一个
A. Harries | M. Oo | Ajay M. V. Kumar | S. Thiha | K. W. Y. Kyaw | N. Kyaw | T. Aung | Y. Mon | T. Win | H. Oo
[1] J. Bartlett,et al. The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania , 2016, Open forum infectious diseases.
[2] J. Farrar,et al. High prevalence of PI resistance in patients failing second-line ART in Vietnam , 2015, The Journal of antimicrobial chemotherapy.
[3] S. Sundar,et al. Outcome of patients on second line antiretroviral therapy under programmatic condition in India , 2015, BMC Infectious Diseases.
[4] J. Farrar,et al. Second-Line HIV Therapy Outcomes and Determinants of Mortality at the Largest HIV Referral Center in Southern Vietnam , 2015, Medicine.
[5] H. Xing,et al. HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China , 2014, BMJ Open.
[6] C. Yiannoutsos,et al. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa , 2014, AIDS.
[7] P. Isaakidis,et al. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India , 2014, Global health action.
[8] B. Ledergerber,et al. Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study , 2014, Journal of the International AIDS Society.
[9] J. Nachega,et al. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings. , 2013, The Journal of infectious diseases.
[10] A. Sohn,et al. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents , 2013, Journal of the International AIDS Society.
[11] L. Fairlie,et al. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents , 2013, Journal of the International AIDS Society.
[12] N. Ford,et al. Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe , 2012, PloS one.
[13] V. Mulenga,et al. The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low-income and middle-income countries , 2012, AIDS.
[14] N. Ford,et al. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis , 2012, AIDS.
[15] K. Freedberg,et al. Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa , 2012, PloS one.
[16] J. Eron,et al. Second‐line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline * , 2010, HIV medicine.
[17] S. Reid,et al. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. , 2010, The Lancet. Infectious diseases.
[18] S. Strathdee,et al. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. , 2008, Addiction.
[19] A. Calmy,et al. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières , 2008, AIDS.
[20] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[21] Richard D Moore,et al. Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 Infection , 2001, Journal of acquired immune deficiency syndromes.